PTPN1
PTPN1 (Protein Tyrosine Phosphatase, Non-Receptor Type 1) is an enzyme that in humans is encoded by the PTPN1 gene. This enzyme is a member of the protein tyrosine phosphatase (PTP) family, which is known to be involved in the regulation of a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation.
Function[edit | edit source]
PTPN1 is a key regulator of several signaling pathways. It functions as a negative regulator of insulin signaling by dephosphorylating the insulin receptor, thereby attenuating the insulin signal. This makes PTPN1 a significant player in the regulation of glucose homeostasis and has implications in diabetes mellitus.
Additionally, PTPN1 is involved in the regulation of other signaling pathways, including those mediated by growth factors, cytokines, and hormones. It has been shown to interact with and dephosphorylate a variety of substrates, including the epidermal growth factor receptor (EGFR), Janus kinase 2 (JAK2), and signal transducer and activator of transcription 5 (STAT5).
Clinical Significance[edit | edit source]
Given its role in insulin signaling, PTPN1 has been studied extensively in the context of type 2 diabetes and obesity. Inhibitors of PTPN1 are being explored as potential therapeutic agents for these conditions. Furthermore, alterations in PTPN1 activity have been implicated in the development of cancer, making it a target of interest in oncology research.
Structure[edit | edit source]
The PTPN1 protein consists of a catalytic domain that is highly conserved among PTP family members. This domain is responsible for the enzyme's phosphatase activity. The structure of PTPN1 includes a signature motif, the PTP loop, which is essential for its catalytic function.
Interactions[edit | edit source]
PTPN1 interacts with a variety of proteins, including:
- Insulin receptor
- Epidermal growth factor receptor
- Janus kinase 2
- Signal transducer and activator of transcription 5
These interactions are crucial for its role in modulating signaling pathways.
Related Pages[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
